Auxilium On a Roll ...
Health Care: Drugs
Endo Pharmaceutical Holdings Inc. (ENDP: NASDAQ)
$30.87 -0.45 | -1.44%
06/04/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 31.32 |
| 52 Week High | 42.09 |
| 52 Week Low | 26.02 |
| Avg. Daily Vol. (Mil) | 1.37 |
| Beta (3 year) | 1.08 |
| Share Related Items | |
| Mkt Cap (Mil) | 3,670.38 |
| Shares Out (Mil) | 117.19 |
| Float (Mil) | 116.51 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.90 |
| Current Ratio | 1.40 |
| LT Debt/ Equity | 1.69 |
| Total Debt / Equity | 1.75 |
| Valuation Ratios | |
| Price Earnings | 92.10 |
| Price/Sales | 1.28 |
| Price/Book | 1.94 |
| Price/Cash Flow | 10.90 |
| Per Share Data | |
| Earnings | 0.34 |
| Sales | 24.41 |
| Book Value | 16.12 |
| Cash Flow | 2.87 |
| Business Summary | |
|---|---|
| Endo Health Solutions Inc is a specialty pharmaceutical company, which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain. | |
| General Information | |
| 100 Endo Boulevard
Chadds Ford, PA 19317 |
|
| www.endo.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 4566 | |
| CEO: David P. Holveck | |
| Short Interest | |
| Current Month (Mil) | 5.72 |
| Previous Month (Mil) | 6.19 |
| Short Interest Ratio (Days) | 4.60 |
| Management Effectiveness | |
| Return on Equity | 2.40 |
| Return on Assets | 0.60 |
| Return on Investments | 0.90 |
| Profitability | |
| Gross Margin | 68.30 |
| EBIT Margin | 10.90 |
| Profit Margin | 1.60 |
Portfolios with ENDP
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ProLee Ainslie - Maverick Capital
- ProD.E. Shaw
- ContributorTechnical Setups for the We...
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- ProChuck Royce - Royce & Assoc...
- ProJohn Hussman
- ContributorTechnical Setups for the We...
- ProZebra Capital
Latest ENDP Headlines from TheStreet
- 7 Stocks Surging on Big Volume 05.29.12 | 01:05 pm
- Downgrades Roundup: SPX, Avon, Shutterfly 05.07.12 | 07:05 am
- Endo Pharmaceutical Holdings Inc. Stock Downgraded (ENDP) 05.03.12 | 05:05 am
- Endo Pharmaceuticals Holdings' CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.01.12 | 03:05 pm
- Endo Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.24.12 | 12:02 pm
- BioSante: A Penny Stock Still Overvalued 02.16.12 | 07:02 am
- UBS: 6 Specialty Pharma Picks to Watch 01.21.12 | 07:01 am
- Endo Pharmaceutical Holdings Inc. (ENDP): Today's Featured Health Care Winner 12.12.11 | 04:12 pm
- 7 Stocks Rising on Unusual Volume 12.12.11 | 12:12 pm
- Endo Pharmaceuticals At 2011 Credit Suisse Annual Health Care Conference Call Transcript 11.11.11 | 02:11 pm
Press Releases for ENDP
- Endo Announces Resolution Of Patent Litigation With Watson Pharmaceuticals Related To Lidoderm® - PR Newswire 05.29.12 | 07:05 am
- Endo Health Solutions Inc. To Present At Jefferies 2012 Global Healthcare Conference - PR Newswire 05.25.12 | 01:05 pm
- Endo Health Solutions Inc. To Present At The Goldman Sachs 33rd Annual Global Healthcare Conference - PR Newswire 05.25.12 | 01:05 pm
- Endo Health Solutions Inc. Announced As New Name For Endo Pharmaceuticals Holdings Inc. - PR Newswire 05.23.12 | 02:05 pm
- Endo Pharmaceuticals To Announce First Quarter 2012 Financial Results On May 1, 2012 - PR Newswire 04.17.12 | 09:04 am
- Qualitest Pharmaceuticals Receives FDA Approval For Levetiracetam Oral Solution, 100 Mg/mL - PR Newswire 04.12.12 | 04:04 pm
- Endo Announces Departure Of American Medical Systems President - PR Newswire 03.29.12 | 01:03 pm
- Endo Acquires Johnson Matthey's Oxymorphone Patent - PR Newswire 03.22.12 | 08:03 am
- BioDelivery Sciences Provides Business Review And Update In Conjunction With Filing Of Its Annual Report - PR Newswire 03.19.12 | 04:03 pm
- Endo Files Amended Citizen Petition Seeking Public FDA Resolution Of Several Safety And Efficacy Issues Prior To Approval Of A Generic Formulation Of LIDODERM® - PR Newswire 03.13.12 | 08:03 am
Partner Headlines for ENDP
- UNVEILED: Analyst Share Price Targets Wednesday - Wall St. Cheat Sheet 05.30.12 | 04:05 am
- Healthcare Biz Recap: HGSI Shareholder Sues, Endo Health Kisses Watson Pharma - Wall St. Cheat Sheet 05.29.12 | 11:05 am
- Auxilium-Glaxo to Drive Testim Sales - Analyst Blog - Zacks 05.22.12 | 10:05 am
- UPDATE: Citigroup Rates Endo Pharmaceuticals as Buy, $48 TP - Benzinga 03.26.12 | 12:03 pm
- BioDelivery Sciences Provides Business Review - Benzinga 03.19.12 | 04:03 pm
- VIX - Options Volatility Sonar: Friday Recap - Seeking Alpha 03.09.12 | 04:03 pm
- Earnings Beat at Endo Pharma - Analyst Blog - Zacks 02.28.12 | 09:02 am
- Stocks To Watch This Week - Seeking Alpha 01.10.12 | 08:01 am
- Billionaire David Shaw's Favorite Stock Picks - Seeking Alpha 12.15.11 | 09:12 am
- Nupathe's Zelrix Going Down A Path With Multiple Headwinds - Seeking Alpha 12.09.11 | 09:12 am
